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Summary
We are interested to know whether expression of a lineage-specific growth factor receptor is
deterministic to lineage commitment during hematopoiesis . For this purpose, we introduced
the human cfms gene into the multipotential stem cell clone LyD9 and two myeloid progenitor
clones, LGM3 and LG3, cells that differentiate in response to granulocyte/macrophage colony-
stimulating factor (GM-CSF) and granulocyte (G)-CSF, respectively. Although LyD9 cells have
differentiation potential to become macrophages, c-fms transfectants ofLyD9 and LGM3 cells
did not differentiate in response to human macrophage (M)-CSF. However, cfms transfectants
ofLG3 cells differentiated to neutrophils in response to human M-CSF. These results indicate
that theM-CSF receptor requires a specific signal transduction pathway to exert its differentiational
and proliferative effects. Furthermore, the M-CSF receptor can convey a granulocyte-type
differentiation signal possibly by cooperating with the GCSF receptor signal transduction pathway.
The cfms-transfected LyD9 cells as well as the original LyD9 cells differentiated predominantly
into GM-CSF- and G-CSF-responsive cells by coculturing with PA6 and ST2 stromal cells,
respectively . The results indicate that differentiation lineage is not affected by premature expression
of the M-CSF receptor. Instead, the stromal cell used for coculture apparently controls lineage-
selective differentiation of the multi-potential stem cell line .
line of evidence has shown that hematopoiesis is regu-
lated by a set of growth factors that bind to specific
receptors expressed on the surface of progenitors as well as
mature blood cells (1~ Especially granulocyte/macrophage
colony-stimulating factor (GM-CSF),' granulocyte CSF
(G-CSF), and macrophageCSF (M-CSF) can induce prolifer-
ation and differentiation of each lineage cell . For example,
thenumber of neutrophils is strongly augmented by adminis-
tration ofG-CSF (2) . Mutant mice that have a defect in the
M-CSF gene have few macrophages (3) . Progenitor cells that
can respond to these lineage-specific CSF appear committed
already to each lineage. Progenitor cells express specific CSF
receptors that can transduce growth and differentiation signal.
Commitment of a multipotential stem cell to myeloid pro-
genitor cells is likely to involve the biochemical events that
induce expression of the lineage-specific CSF receptor.
'Abbreviation used in this paper: GM-CSF, granulocyte/macrophage colony-
stimulating factor.
Hematopoiesis is also regulated by direct contact of stem
cells with stromal cells. In a long-term bone marrow culture
system, hematopoiesis ofvarious lineage cells can be sustained
by bone marrow stromal cells without exogenous growth
factors (4-6) . We have recently shown that coculture of a
multipotential stem cell line, LyD9, with the PA6 and ST2
stromal cell lines (7, 8) can support differentiation into GM-
CSF-responding and GCSF-responding cells, respectively (9) .
The GM-CSF-responsive clone (LGM3) thus obtained dif-
ferentiated into macrophages and neutrophils in response to
GM-CSF. The G-CSF-responsive cell clone (LG3) differen-
tiated into neutrophils in response to G-CSF. Neither the
PA6 nor the ST21ine was able to support differentiation of
M-CSF-responsive cells, although M-CSF was produced by
bothPA6 and ST2 lines (10) . These results indicate that prod-
ucts secreted from or expressed on the stromal cells might
play decisive roles in induction of CSF-specific functional
receptors on multipotential cells .
Conveyance ofregulatory signals by growth factors depends
on establishment of at least three biochemical systems : (a)
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duction pathways, and (c) chromatin opening or transcrip-
tion competency of the growth factor-responsive genes. We
wish to know whethertheexpression of receptors for lineage-
specific growth factors affect differentiationandcommitment.
For this purpose,we have chosen the human M-CSF receptor
as the receptor by the following reasons : (a) M-CSF almost
exclusively increases macrophage lineage cells ; (b) the single
chain of the M-CSF receptor encoded by the human cfurs
gene (11) is fully active for signal transduction (12) ; and (c)
as human M-CSF receptor does not bind murine M-CSF,
we can avoidautocrinegrowth as well as selective expansion
of M-CSF-responding cells until we add human M-CSF.
Throughout this study, humanM-CSFwas used unless other-
wise indicated.
We have introduced thehumanM-CSF receptor gene into
LyD9, LGM3, and LG3 cells, and tested whether M-CSF
could direct differentiationofcfmstransfectants ofLyD9 cells
and its derivatives into macrophages . We found that the
M-CSF receptor expression alone did not allow these cells
to differentiate into macrophages in response to M-CSF. We
also found that premature expression of the M-CSF receptor
on LyD9 andIrGM3 cells could not affect the differentiation
lineage that is regulatedby the specific stroma cell lines(PA6
and ST2) used for the coculture. These results indicate that
expression of a lineage-specific growth factor receptor alone
is not sufficient for lineage commitment of the multipoten-
tial cell and that the stromal cell used for coculture appar-
ently controls differentiation lineages.
Materials and Methods
Cytokines.
￿
rIL3, rI1r4, and rIL5 were obtained from culture
supernatants of X63Ag8 myeloma cells transfected with murine
IL3, 11,4, andID5 cDNA, respectively (13) . Oneunit ofIL3, 11,4,
and IL5 was defined as the amounts of the supernatants that gave
a halfof themaximal proliferative response to LyD9, K4 (14), and
K5 cells (15), respectively . Murine rGM-CSFandrG-CSF were cul-
ture supernatants ofCHO cells transfected with respective cDNAs,
which were kindly provided by Dr. T . Sudo (Biomaterial Institute
Co . Ltd., Kanagawa,Japan) . The activities ofGM-CSF andG-CSF
were measured using IC-2 andNFS-60 cells . HumanrM-CSF was
purchased from Genzyme (Boston, MA) .
Cell Lines .
￿
The procedures for the establishment and detailed
characterization ofLyD9, LS-1, LGM, andIG were described (9,
14, 16) . LS-1,LGM3, and LG3 were established as clones by lim-
iting dilution of LS, LGM, andIG cell lines. LS-1, LGM3, and
LG3 cells have indistinguishable phenotypes of parent cell lines
LGM and LG, respectively. All of them were maintained in the
complete medium (RPMI 1640, 10% FCS, 50 AM 2-ME, 2 mM
L-glutamine) supplemented with rIL3 (10U/ml). Stromal cell clones
ST2-S10 (ST2) andMC3T3-G2/PA6 (PA6) were established from
bone marrow ofNZBmice andmaintained in theRPMI 1640 con-
taining 5% FCS and 50 AM 2-ME .
Coculture with Stroma Cells.
￿
The detailed methods and results
ofthe coculture ofLyD9 and stromal cells PA6 and ST2were de-
scribed (9) . Before coculture with stroma cells, c-fins-expressing
cells to be cocultured with PA6 cells were treated with 5-azarytidine
in the following way. 5-azarytidinewas added to 5 Wg/ml in 5 ml
IL3-containing complete medium with 106 cells/ml . After 24 h,
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5 ml of freshmedium without 5-azarytidinewasadded andmain-
tained for 3 d. Cells were washed and expanded with rID3 for the
coculture . It wasdemonstrated that GM-CSF-responding cells were
generatedwith coculture ofPA6without 5-azarytidine treatment,
but this treatmentpromoted the generation ofCSF-responding cells .
Coculture was performed in T25 flasks (Corning Glass Works,
Corning, NY) containing monolayers of PA6 or ST2 cells . c-ms-
expressing cells were added (5 x 105 cells/flasks) in 5 ml of the
complete medium supplemented with IL-3 (1-3 U/ml) . Themedium
was half changed every 4 d with the same medium . After 2 wk
of the coculture, cells cocultured with PA6 andST2 stromal cells
were harvested and transferred torGM-CSF (20U/ml) or rG-CSF
(20 U/ml) containing medium, respectively. Cells were cultured
further for3 d, andthen expanded with 11,3 .GM-CSF-responding
lines LyD9/fms-1/GM and LyD9/fms-2/GM were obtained from
LyD9/fms-1 andLyD9/fms-2, respectively. G-CSF-responsive cell
line LyD9/fms-1/Gwasobtained from LyD9/fms-1 cells. LyD9/fms-
2/GM were further cocultured with ST2 as described above and
established as a cell line that responded to G-CSF
(LyD9/fms-2/GM/G) .
Transfection ofHuman c.fms Gene.
￿
The intacthumanc-fms gene
in the heavy metal-inducible expression vector and its mutant
form(F) in themurine retroviral vector(pZip neoSVX) were kindly
provided by Drs. Kato and Sherr (17) . Tyrosine at position 996 is
replaced with phenylalanine in the mutant form . The product of
the mutant cfms(F) is disrupted in a negative regulatory domain
near theCOOH terminus and is more efficient than its wild-type
counterpart in signal transduction . The cfms gene was electropo-
rated into LyD9, IrGM3, andILG3 with pSV2neo genes, and the
selection was startedwith 1 mg/ml G418 after 48 h . After2wk,
G418-resistant cells were stained with amAb against ahuman cfms
product (mAb 3-4A4 ; Oncogene Science Inc., Manhasset, NY) and
subjected to single cell sorting usingFACStar® (BectonDickinson
&Co., Mountain View, CA). Cells were expanded with rIL3 in
the presence of G418, 10 -4M ZnS04, and 5 x 10 - 'M CdS0 4 .
Thecfms (F) gene was transfected into the 02 cells, and transfec-
tantswere selected with 1 mg/ml G418 . The cfms-expressing02
cells were sorted by staining with mAb 3-4A4 and expanded for
infection.LyD9,LGM3, andLG3 were cultured on the monolayer
of the c-fins-expressing *2 cells for 2 d in the complete medium
containing rIL3 and 5-20 wg/ml of polybrene (Sigma Chemical
Co ., St . Louis, MO). Cells were harvestedandexpanded with rIL3
and G418 for the single cell sorting as described above . All of the
c-fins-expressing clones were checked for thegrowth factor depen-
dence andmorphology. The experiments were performedwith cells
keeping the phenotypes of the parent cell lines .
Colonyforming Assays.
￿
Colony-forming abilities of LyD9 and
LS-1 cells were assayed by their growth in semi-solid agar (0.3%,
Bacto-Agar; Difco Laboratories, Detroit, MI) supplemented with
growth factors indicated . The results are the average in the tripli-
cate. Colonies arecomposed of >50 cells and clusters are<50 cells.
Scatchard Plot Analysis. Pure murine rGM-CSF (non-
glycosylated) was kindly provided by Kirin Brewery Pharmaceu-
ticalLab. (Gunma, Japan) . Iodination ofGM-CSF was carried out
using the modified two-phase chloramine T method (18) . The
specific radioactivity of the '31-labeled GM-CSF was 57,000 cpm/ng,
estimated by the self-displacement analysis. Murine rG-CSF was
radioiodinated by the IODO-GEN method as described (19) . For
GM-CSF receptors, cells (3 x 106/tube) were incubated in 200 g1
ofRPMI 1640 containing 10 mg/mlBSA, 25 mM Hepes(pH7.4),
and various amounts of 1251-GM-CSF at 37°C for 30 min . Each
aliquot was layered on a 200-Al mixture of olive oil and dibutyl
phthalate (1:4), and centrifuged at 5,000 rpm for 2 min . Cell-bound(B) and free(F) radioactivity were quantitated with thegamma
counter. Nonspecific binding was determined by the addition of
a 60-fold molar excess of unlabeled GM-CSF. The binding assay
ofG-CSF was done as above except that cells (10') were incubated
at 4°C for 4 h with various concentrations of 12'I-G-CSF in 0.3
ml of RPMI 1640 containing 10% FCS and 20 mM Hepes (pH
7.4) . A large excess ofunlabeled G-CSF was included to determine
the nonspecific binding .
Immune Complex KinaseAssay.
￿
Cell lysates were prepared from
10' cells of transfectants and parent cell lines with 1 ml of RIPA
buffer (50 mM Tris HCI, pH 7.4, containing 150 mM NaCl, 20
mM EDTA, 1% Triton X-100, 1% sodium deoxycholate) with2%
aprotinin and 1 mM phenyl-sulphonylfluoride . Cell lysates were
precleared with Pansorbin (Calbiochem-Behring Corp., La Jolla,
CA) coupled with rabbit anti-rat IgG (Zymed Laboratories, San
Francisco, CA) . Immune complexes were prepared by the addition
ofmAb 3-4A4 and incubation at 4°C for 1 h, and then immuno-
precipitated with Pansorbin coupled with anti-rat IgG . Precipi-
tates were washed five times withRIPAbuffer and then twice with
50 mM Tris HCI (pH 7.4) . Kinase reactions were performed as
described (12) . Products were analyzed in SDS-polyacrylamide gels
and detected by autoradiography of the dried gel .
Northern BlotAnalysis.
￿
TotalRNA was isolated by using guani-
dine isothiocyanate and centrifuging over the cushion of cesium
chloride (20). Northern blot analysis was perform using 20 fig RNA
as described (21) . Blotted filters were hybridized with human cfms
cDNA (BamHI fragment) labeled with a-["P]dCTP (3,000
Ci/mmol ; American Corp., Arlington Heights, IL), and rehybrid-
ized with human fl-actin probe to quantitate RNA.
Morphology.
￿
Cells were cytospinned to slide glasses and exam-
ined with May-Gruwald-Giemsa stain . Histochemical analysis was
performed for myeloperoxidase, naphthol AS-D chloroacetate es-
terase, and tx-naphthylbutyrate esterase using a staining kit (Mutoh
Chemicals, Tokyo, Japan) . Phagocytosis was determined as de-
scribed (14) .
Results
Expression of Receptors for CSF in LyD9 and Its Deriva-
tives. We first examined expression ofreceptors forGM-CSF,
GCSF, andM-CSF by the ligand binding assay or by Northern
blot analysis . As shown in Fig. 1 A, LyD9 and LG3 cells
did not show any specific binding ofGM-CSF, whereas LGM3
cells showed significant specific binding. The Scatchard plot
analysis showed that LGM3 cells expressed "5,400 GM-CSF
receptors per cell with a single Id value of 80 pM . The
results are consistent with previous studies, which stated that
LGM3 cells responded to GM-CSF, resulting in prolifera-
tion and differentiation, whereas LyD9 and LG3 cells did
not (9) . In contrast, the G-CSF receptor was expressed on
not only LG3 but also LyD9 cells, as shown in Fig. 1 B .
LyD9 and LG3 cells expressed "400 and "800 receptors,
respectively, per cell with the same affinity as that ofNFS60
cells from which theG-CSF receptor cDNA was cloned (22) .
As shown previously LG3 cells differentiated into neutro-
phils in response to G-CSF (9) . We have not, however, de-
tected any effects ofG-CSF on LyD9 cells with or without
the addition of 11,3 or IL4 . As expected, LGM3 cells did
not express a detectable level of theG-CSF receptor. NFS60
proliferated without differentiation in the presence ofG-CSF.
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To assess M-CSF receptor expression, we performed
Northern blot analysis of mRNAs using the cfms probe.
As shown in Fig . 1 C, only an M-CSF-responding cell line,
LS-1 (see below), expressed c-fms mRNA . Other cells (LyD9,
LGM3, and LG3), which did not respond to M-CSF, did
not express cfms mRNA . Among LyD9 and its derivative
cell lines, the expression ofGM-CSF and M-CSF receptors
is correlated with their response to the growth factors. How-
ever, the G-CSF receptor expressed on LyD9 cells could not
convey proliferative or differential signals .
LyD9 Cell Line Has Potential to Differentiate into Macro-
phages. Previous studies showed that LyD9 cells gave rise
to myeloid cells as well as B cellswhen cocultured with pri-
mary bone marrow stroma cells (14) . TheLS series ofLyD9
derivatives was established after transferring LyD9 cells cocul-
tured with primary stroma cells onto a cloned stroma cell
line, ST2 . M-CSF-dependent cellsmay have been selected be-
cause a largeamount ofM-CSF was secreted fromST2 . Mor-
phological characterization of these cells was briefly described
previously (14) .
As shown in Table 1, one of the LS series clones, LS-1,
formed colonies with decreasing frequency in the presence
ofGM-CSF, 11,3, M-CSF, IIA, andGCSF. 11,3 induced com-
pact colonies . GM-CSF induced mainly compact, but some
diffuse colonies as well. On the contrary, M-CSF induced
only diffuse colonies, as shown in Fig. 2 . When LS-1 cells
were cultured with M-CSF for 1 wk, Mac-1 expression in-
creased (data not shown), and most cells showed vacuolated
cytoplasm . PMA stimulation of LS-1 cells augmented
nonspecific phagocytosis . It is interesting to note that there
were a small number of neutrophils positive for specific es-
terase and myeloperoxidase in LS-1 cells cultured in M-CSF
for 7-10 d . In the presence of IL3, the majority of LS-1 cells
were immature blast cells, although very few myeloperoxidase-
positive neutrophils and nonspecific esterase-positive macro-
phages were also found .
LyD9 cells could grow only in the presence of IL-3 and
formed compact colonies . Although some of cells express
Mac-1 and are weakly positive for nonspecific esterase, LyD9
cells did not show any evident signs of differentiation (9, 14) .
LGM3 cells respond to eitherGM-CSF or 11,3 mainly with
proliferation, but some myeloperoxidase and specific esterase-
positive neutrophils as well as macrophages with phagocytic
activities also appeared .
Induction and Expression of the Human cfms Gene in LyD9
and its Derivatives . To test whether expression oftheM-CSF
receptor would modify differentiation ofLyD9, LGM3, and
LG3 cells, we introduced the human cfms gene into these
cells . We used the wild-type (Y)996 and mutant-type (F)9%
of the cfms gene (12) . This replacement of tyrosine with
phenylalanine at residue 996 augments M-CSF-dependent re-
sponse without transformation . Transfected cells obtained were
selected with G418 in medium containing IL-3 . 2 wk after
transfection, G-418-resistant cells obtained were stained with
anti-human cfms mAb and subjected to single cell sorting
for cloning . Surface expression of the M-CSF receptor on
cloned transfectants is shown in Fig. 3A . The remaining
clones expressed a similar number of M-CSF receptors .Added GM-CSF(pM)
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Figure 1 .
￿
Expression ofCSF receptors ofLyD9 and its
derivatives. Saturation ofbinding and Scatchard plot anal-
yses of 1251-GM-CSF (A) and 1251-G-CSF (B) . Cells were
incubated with 1251-GM-CSF or 1251-G-CSF with or
without excess amounts of homologous unlabeled CSFs
as described in Materials and Methods . (C) Northern blot
analysis ofcfms expression. Lane 1, 5-azacytidine-treated
LyD9 ; lane 2, LyD9 ; lane 3, L.GM3; lane 4, LS-1; lane
S, L.G3. The filter was hybridized first with cfms genes
and then rehybridized with S-actin probe. Autoradiogra-
phies wereperformed at -70°C for 48 h (cfms) and 20 h
(0-actin) .
Cells (6 x 103 cells) were grown in the soft agar containing IL-3 (100 U/ml), IL-4 (100 U/ml), IL-5 (150 U/ml), GM-CSF (50 U/ml), G-CSF
(150 U/ml), or M-CSF (100 U/ml) . The results using 6 x 104 cells are shown in parentheses . Colonies (>50 cells) and clusters (<50 cells) were
counted on day 7 .
Table 1.
Cell lines
Colonyforming Assay ofLyD9 and LS-1
IL-3
Cells
IL-4
Growth
IL-5
factors
GM-CSF M-CSF G-CSF
LyD9 Colonies 67(ND) 0(0) 0(0) 0(0) 0(0) 0(0)
Clusters ND(ND) 0(20) 0(0) 0(0) 0(0) 0(0)
LS-1 Colonies 628(ND) 0(880) 0(0) 783(ND) 272(ND) 0(23)
Clusters ND(ND) 0(ND) 0(123) ND(ND) ND(ND) ND(217)1271
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0 ;;To see whether the expressed cfms proteins were functional,
we performed in vitro kinase assay. As shown in Fig. 3 B,
two phosphorylated proteins were generated in all transfec-
tants . The sizes ofphosphoproteins were consistent with those
of earlier reports, which demonstrate that the larger band
is a mature protein formed by the glycosylation of the smaller
band . During the selection with 11r3 and G418, some of the
transfectants of LGM3 and LG3 cells lost the dependency
on GM-CSF and G-CSF, respectively. All experiments for
the present study, however, were carried out on transfectants
that preserved the growth factor requirement of the parent
cells .
Responsiveness ofc-fms Transfectants toM-CSF .
￿
We then in-
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Expression of human
c- ms product. (A) Surfirce expres-
sion ofhuman cfms product of cells
transfected with c-fms wild (Y) or
mutant (F) genes were confirmed
with thesurface staining withmAb
3-4A followed by FITC-labeled
anti-rat IgG as a second antibody.
(a) LyD9/fms-1 ; (b) LyD9/fms-2; (c)
LyD9/firs-22 ; (d) LGM3/fins-3 ; (e)
LGM3/fms-10; (/) LGM3/fms-(F)-
3 ; (g) LG3/fins-3; (b) LG3/fms-11 ;
(i) LG3/fms-(F)-7 . Solid lines rep-
resent staining patterns with the
first and second antibodies, and
broken lines represent negative con-
trol stained only with second anti-
body. Patterns of untransfected
parent cells stained first withthe first
and second antibodies were iden-
tifical with that of the second anti-
bodyonly . (B) In vitro Knase assay.
Kinase activities ofexpressed human
cfmswereanalyzed with cell lysates
prepared from: lane 1, LyD9; lane
2, LyD9/fms-1 ; lane 3, LyD9/fms-
2 ; lane 4, LyD9/fms-4; lane 5,
LyD9/fms-(F)-2; lane 6, LyD9/fms-
(F)-21 ; lane 7, LyD9/fms-(F)-22 ;
lane 8,LGM3 ; lane 9, LGM3/fms-
3 ; lane 10, LGM3/fms-10; lane 11,
LGM3/fms-(F)-1; lane 12,LGM3/
fms-(F)-3; lane 13, LGM3/fms-(F)-
6 ; lane 14,LG3 ; lane 15, LG3/fms-
3 ; lane 16, LG3/fms-11 ; lane 17,
LG3/fms-(F)-1 ; lane 18, LG3/fms-
(F)-7. Kinase assay was performed
as described in Materials and Meth-
ods .
vestigated growth responsiveness of the cfms transfectant to
human M-CSF. All three LyD9/fms clones failed to grow .
They survived slightly longer than LyD9 cells, but all cells
were dead by day 3 (Fig. 4A) . LyD9/fms(F) clones showed
a transient growth surge for 2 d and declined rapidly.
LyD9/fms(F) cells showed slightly augmented responses to
M-CSF as expected from the observation that the replace-
ment oftyrosine at residue 996 with phenylalanine increases
the size and the number ofM-CSF colonies ofNIH3T3 cells
bearing cfms (12) . While LS-1 cells displayed M-CSF-
dependent growth, it is clear that the M-CSF receptor ex-
pressed on LyD9 cells failed to convey signals for continued
proliferation .10'
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The same pattern was observed for all but one of the
LGM3/fms clones (Fig . 4 B) . LGM3/fms(F) showed a tran-
sient response pattern, but declined thereafter . LGM3/fms
showed the similar response to a less degree . One clone,
LGM3/fms(F)-1, continued to proliferate in the presence of
M-CSF. It expressed a similar amount of c-ms proteins to
other LGM3/fms clones, and its growth is still dependent
on M-CSF. We have not characterized any further difference
between LGM3/fms(F)-1 and the other clones. As theLGM/
fms(F)-1 phenotype is relatively rare, the secondary events
might be required for cfms transfectants ofLyD9 and LGM3
cells to acquire the proliferation capability in response to
M-CSR
In contrast, all LG3/fms clones showed prolonged survival
in the presence ofM-CSF (Fig. 4 C) . I7G3 transfectants bearing
either the wild or mutant type of the M-CSF receptor dou-
bled in number after 24 h and maintained their viability for
up to 2 wk . G-CSF induced a similar growth profile except
for a longer period up to 18 d.
Differentiation ofc.fms Transfectants with M-CSF .
￿
We tested
whether M-CSF could alter morphological and cytochem-
ical properties of the cfms transfectants. LyD9/fms cells showed
immature morphology in the presence of M-CSF and did
not change this phenotype on day 2, 1 d before death (data
not shown) . LGM3/fms as well as LGM3 cells cultured in
the presence of either I1r3 or GM-CSF contained asmall frac-
tion of neutrophils and macrophages among immature cells
(9) . Culturing in M-CSF did not change this morphology
of the LGM3/fms cells on day 3-4 . Most of the LGM3/
fms(F)-1 cells, which proliferated continuously in M-CSF, were
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days
Figure 4.
￿
Growth responses to M-CSR Growth profiles of cfms transfectant of clones LyD9(A), LGM3(B), and LG3(C) cells in the presence of
M-CSF (50 U/ml). 1-2 x 106 cells were grown in 5 ml of the complete medium with or without M-CSF, and the medium was changed with the
fresh one every third day . Viable cells were counted with the trypan blue exclusion . LS-1 cells were included as a positive control and untransfected
parent cells as a negative control. Growth pattern of cfms-transfected clones without M-CSF were similar to those ofparent cell lines . In C, growth
response of L-G3 cells to G-CSF was included for comparison .
immature with few mature macrophages and neutrophils (data
not shown) .
WhenLG3/fms cells were cultured with G-CSF, these cells
began to differentiate on about day 7, and most of the cells
became typical mature neutrophils by day 14 (Fig. 5, c and
h) . When ILG3/fms were cultured in M-CSF-containing
media, they showed not only similar growth responses (Fig.
4 c), but also similar differentiation profiles (Fig . 5, d and
i) to those induced by G-CSF. Morphological changes be-
came apparent around day 7 . Mature neutrophils occupied
20-50% of the population between days 9 and 14 . The re-
maining cells were still immature without monocytic mor-
phological properties such as enlarged and vacuolated
cytoplasm, nonspecific esterase, and phagocytic activities,
which were typically found in LS-1 cells treated withM-CSF.
IrG3 transfectants bearing the mutant type (F) ofcfms tended
to produce more neutrophils than those bearing the wild-
type (Y) (Fig. 5, e and,/ . LG3/fms remained immature in 11,3 .
Differentiation ofLyD9/fms Cells by Stromal Cells.
￿
Finally,
we tested whether earlier expression of the M-CSF receptor
on LyD9 cells would affect the differentiation lineage regu-
lated by cocultured stromal cells (9) . LyD9/fms-1 and
LyD9/fms-2 were cultured withPA6 stromal cells in the pres-
ence of a minimal amount of IL3 for 2 wk . Nonadherent
cells were harvested and expanded with GM-CSR Two cell
lines, LyD9/fms-1/GM and LyD9/fms-2/GM, thus established
were dependent on either GM-CSF or I1r3 . Most of them
proliferated without differentiation in the presence of IL-3
or GM-CSF, but some ofthe cells did differentiate into mac-
rophages and neutrophils (Fig . 5, a andf) . Neither LyD9/fms-
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￿
Induction ofM-CSF responsiveness after coculture with stromal
cells. Growth responses of LyD9/fms-1/GM and LyD9/,fms-1/G cells to
GM-CSF (20 U/ml), G-CSF (50 U/ml), and M-CSF (50 U/ml) were mea-
sured as described in the legend to Fig . 4 .
1/GM nor LyD9/fms-2/GM cells were induced to proliferate
and differentiate in response to human M-CSF (Fig. 6) . No
cell lines were obtained even when nonadherent cells were
cultured inhumanM-CSR Expression oftheM-CSF receptor
on LyD9/fms-1 (or -2)/GM cells was confirmed by surface
staining with the anti-human cfms antibody (data not shown) .
LyD9/fms-1 cells were cocultured with ST2 stromal cells
to induce G-CSF-dependent lines. After 2 wk of coculture,
nonadherent cells were harvested and maintained withGCSF
for 2 d, and then expanded and maintained with IL3 . The
growth response of this line (LyD9/fms-1/G) to G-CSF and
M-CSF is shown in Fig . 6 . LyD9/fms-1/G responded to both
G-CSF and M-CSF with the same prolonged survival pat-
tern as found in IrG3/fms cells. LyD9/fms-1/G cells survived
for ti 18 d in G-CSF but form , 12 d in M-CSR Morpholog-
ical studies showed that most of the LyD9/fms-1/G cells
differentiated into neutrophils in the presence of G-CSF,
whereas 30--40% of cells were neutrophils in the presence
ofM-CSF. Identification of neutrophils was based on ringed
or segmented nuclei, and myeloperoxidase production (Fig .
7) . None of LyD9/fms-1/G cells cultured in M-CSF showed
any characteristics of macrophages such as phagocytosis and
expression of nonspecific esterase (data not shown) . Similar
lines were obtained when M-CSF was added in place ofG-CSF
for 2 d before maintaining the cells in IL3 .
Similar differentiation induction experiments using ST2
stroma cells were done withLGM3/fms and LyD9/fms/GM
cells . G-CSF-responsive derivative lines ofLGM3/fms and
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LyD9/fms/GM cells were obtained by culturing for 2 d in
GCSF-containing media and subsequent expansion with 11,3
after coculture with ST2 cells . When these derivatives were
further cultured with either G-CSF orM-CSF, they differen-
tiated into neutrophils but not macrophages in a similar
manner, as mentioned above (Fig . 7) . When the cells cocul-
tured with ST2 stromal cells were transferred directly to
M-CSF-containing media, they also differentiated into neu-
trophils but not macrophages (data not shown) . These results
indicate that premature expression of the M-CSF receptor
does not direct the monocytic commitment of LyD9, LGM,
and LG3 clones, nor does it alter particular differentiation
lineage induced by coculture with specific stromal cells .
Discussion
We have tested whether forced expression of the M-CSF
receptor in a multipotential stem cell line and myeloid pro-
genitor cellswould affect determination ofdifferentiation lin-
eage. The multipotential cell line LyD9 proliferates without
differentiation in response to IL3 and has been shown to
differentiate into neutrophils, macrophages, and B lympho-
cytes by coculture with different stromal cells (9, 14, 23-25) .
IrGM3 and IrG3 cells derived from LyD9 cells proliferate
and differentiate in response to GM-CSF and G-CSF, respec-
tively (9) . We found that the M-CSF receptor expression in
these stem and progenitor cells and progenitor cells did not
induce differentiation into macrophages in the presence of
M-CSF. Instead, cfms transfectants of1,G3 cells differentiated
into neutrophils in response to M-CSF. The results clearly
indicate that the M-CSF receptor requires a signal transduc-
tion system different from those of the IL3, GM-CSF, and
G-CSF receptors . Furthermore, the signal transduction path-
way of the M-CSF receptor seems to cooperate with that
of the G-CSF receptor.
We have also tested whether the premature expression of
the M-CSF receptor in the multipotential stem and progen-
itor cells would affect the direction of differentiation induced
by coculture with stromal cells . We found that the myeloid
lineage ofdifferentiation was controlled primarily by the type
of stromal cells used for coculture regardless of the prior ex-
pression of the M-CSF receptor in the stem and progenitor
cells.
The differentiation induction through a growth factor
receptor depends on expression of at least three sets of gene
products whose functions are tightly linked : (a) the growth
factor receptor, (b) cytoplasmic signal transduction machinery,
and (c) transcriptional machinery that makes target genes ready
for induction. In other words, the growth factor receptor
cannot induce proliferative or differentiational effects if any
of the components in categories b and c is not expressed in
progenitor cells . The cfms transfectants of LyD9, LGM3,
and L-G3 cells were unable to transduce the M-CSF-specific
signals even though they express the M-CSF receptor that
can catalyze phosphorylation . It is not clear which of cyto-
plasmic signal transduction and transcriptional machineries
specific to the M-CSF receptor is missing in these cells . Al-
though the cfms transfectants oftheLG3 and other G-CSF-Figure 7 .
￿
M-CSF- and G-CSF-induced differentiation of cfms transfectants cocultured with ST-2 stromal cells. LyD9/fms-1G (a--d) were
with May-Granwald-Giemsa (a and c) and myeloperoxidase (b and d) after culturing with 50 U/ml G-CSF (a and b), or 50 U/ml M-CSF (b
Cells derived from LyD9/fms-2/GM cocultured with ST2 stromal cells were cultured with 50 U/ml G-CSF (See Materials and Methods) (i
U/ml M-CSF (f), and stained with May-Granwald-Giemsa .
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into granulocytes in response toM-CSF, it is not clear where
the signal from the M-CSF receptor crossed the GCSF-specific
pathway. This crossing can take place at either the cytoplasmic
signal transduction machinery or the selection oftarget genes.
Since a high concentration ofM-CSF has been shown to stimu-
late neutrophil development, as shown in LS-1 and other cells
(26), the differentiation induction machineries ofM-CSF and
G-CSF appear to cross or share some components.
It has been long debated whether the interaction of the
growth factor and its receptor is deterministic to lineage com-
mitment . As mentioned above, the expression of the growth
factor receptor alone can not be deterministic. The growth
factor may appear to determine lineage commitment when
the whole differentiation induction system, including the
receptor, cytoplasmic signal transduction machinery, and tran-
scriptional machinery, is ready in progenitor cells. However,
one can argue that the cell at this stage has been already com-
mitted to the lineage to be induced by the growth factor.
Choice of a single cell lineage from several potentials is likely
to involve a series of biochemical events as described above.
In this sense, lineage commitment may be a continuous pro-
cess until the genes involved in the growth factor differentia-
tion induction are all expressed . Onlywhen a progenitor cell
has established differentiation induction systems for multiple
growth factors can one of the growth factors be deterministic
(27) . It is important to know how the differentiation induc-
tion system for a lineage-specific growth factor is activated
in the progenitor cell .
Our accompanying study (9) indicates that coculture with
different stromal lines support differentiation of the LyD9
stem cell line into specific lineages . It has been shown that
direct contact between LyD9 cells and stromal lines is essen-
tial for differentiation . We have now shown that the prior
expression oftheM-CSF receptor does not alter the differen-
tiation program controlled by the stromal cell lines . Although
LyD9 cells were induced to differentiate into macrophages
by coculture with heterogenous primary stromal cells, ST2
and PA6 stromal lines could not replace them for macrophage
differentiation ofLyD9 cells . As both ST2 andPA6 stromal
cells produce murine M-CSF, their inability to support mac-
rophage differentiation should be explained by the absence
of either unknown growth factors produced by stromal cells,
interaction through cell adhesion molecules, or their combi-
nation .
Other groups ofinvestigators have shown that transfected
cfms is able to transduce proliferative and/or differentiation
signals in myeloid and pre-B cell lines. Human cfms-transfected
32D cells, which are G-CSF responsive and similar to IrG3
cells, were able to proliferate continuously and to differen-
tiate reversibly to macrophages in response to M-CSF (28) .
These results are in a sharp contrast to our own but are not
necessarily contradictory. The two cell lines must differ in
the expression of component of the M-CSF differentiation
induction system . It is not surprising that there are multiple
intermediate stages ofexpression of components ofthe differen-
tiation induction system for lineage-specific growth factors.
cfms transfectants of another myeloid progenitor line, FDC-
P1, which is similar to the ITGM3 cells, can proliferate con-
tinuously in the presence of M-CSF (17) . A similar study
using murine cfms showed c.fms transfectants of FDC-P1
cells proliferate and differentiated reversibly into macrophages
in response to murine M-CSF (29) . FDC-P1 and 32D cells
appear to contain necessary components of theM-CSF differen-
tiation induction system .
A cfms-transfected clone (DIF9) of 1177-responding cells
was isolated by selection in lymphocyte-growing media with
M-CSF . DIF9 cells could proliferate and differentiate irre-
versibly into macrophages by shifting to myeloid-growing
media with M-CSF (30) . Although this study has concluded
that signals mediated by the transfectedM-CSF receptor play
a deterministic role in cell differentiation, it remains to be
seen whether this observation is general and physiological
because of the following reasons . (a) The lineage switching
requires not only M-CSF but also myeloid-growing media .
In fact, DIF9 cells kept pre-B phenotype in RPMI 1640 con-
taining M-CSF. (b) To claim the lineage switching, it is im-
portant to show that DIF9 cells retain the maturation poten-
tial to B cells. Although DIF9 cells proliferate in response
to 11,7 and have rearranged the Ig heavy chain loci, DIF9
cells do not express the it chain protein . DIF9 cells could
be in a dead end of differentiation into B lymphocytes . (c)
Only a single clone of cfms transfectants showed the "lin-
eage switching" phenotype. It must be a very rare event even
if it can happen .
In addition to difference in expression of the M-CSF
differentiation induction system, experiments described above
may contain in vitro artifacts that can arise from usingM-CSF
during selection ofcfms transfectants . We are careful to avoid
such artifacts and always tested both mixed populations and
independent clones . In fact, we also isolated one ITGM3/
cfms clone that proliferated continuously in response to
M-CSR It maybe possible therefore that relatively rareM-CSF-
responsive cells could only be selected by culturing in M-CSF-
containing media (30, 31) .
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